Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-10

Clinical Trial Update: Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for YYD302 in knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YYD302

Snippet

Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED